stdClass Object
(
    [id] => 16428
    [paper_index] => 202506-02-022164
    [title] => BEST PRACTICES FOR IMPROVING THE QUALITY OF INDIVIDUAL CASE SAFETY REPORTS IN PHARMACOVIGILANCE
    [description] => 
    [author] => Mr. Siddheshwar S. Rajurkar , Ms.Ashwini Shelke, Dr. Sunil. S. Jaybhaye, Dr. Swati. Rawat, Mr. Rushikesh D. Dhavle
    [googlescholar] => 
    [doi] => 
    [year] => 2025
    [month] => June
    [volume] => 10
    [issue] => 6
    [file] => fm/jpanel/upload/2025/June/202506-02-022164.pdf
    [abstract] => Pharmacovigilance is an important and integral part of clinical research. Pharmacovigilance is “defined as the pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short-term adverse effects of medicines. This addresses what exactly is pharmacovigilance. What do we know of its benefits and risks, challenges and the future hold for pharmacovigilance in Indian medicine. Here the main focus on the aims and role of pharmacovigilance in medicines regulation and their Partners.
    [keywords] => Pharmacovigilance, Components of Pharmacovigilance, Objectives of Pharmacovigilance, Types of Pharmacovigilance
    [doj] => 2025-06-06
    [hit] => 
    [status] => 
    [award_status] => P
    [orderr] => 24
    [journal_id] => 2
    [googlesearch_link] => 
    [edit_on] => 
    [is_status] => 1
    [journalname] => EPRA International Journal of Research & Development (IJRD)
    [short_code] => IJSR
    [eissn] =>  2455-7838 (Online)
    [pissn] => - -
    [home_page_wrapper] => images/products_image/2-n.png
)
Error fetching PDF file.